- Home
- HGLB vs RGC Comparison
HGLB vs RGC Comparison
Compare HGLB & RGC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | HGLB | RGC |
|---|---|---|
| Founded | N/A | 2014 |
| Country | United States | Hong Kong |
| Employees | N/A | N/A |
| Industry | Trusts Except Educational Religious and Charitable | Medicinal Chemicals and Botanical Products |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 209.5M | 11.5B |
| IPO Year | 2015 | 2020 |
Fundamental Metrics
Financial Performance| Metric | HGLB | RGC |
|---|---|---|
| Price | $7.76 | $25.39 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | 69.9K | ★ 97.5K |
| Earning Date | 01-01-0001 | 10-31-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $6.62 | $9.39 |
| 52 Week High | $10.64 | $950.00 |
Technical Indicators
Market Signals| Indicator | HGLB | RGC |
|---|---|---|
| Relative Strength Index (RSI) | 16.76 | 48.42 |
| Support Level | N/A | $24.31 |
| Resistance Level | $9.07 | $26.42 |
| Average True Range (ATR) | 0.28 | 2.28 |
| MACD | -0.08 | 0.18 |
| Stochastic Oscillator | 7.63 | 38.89 |
Price Performance
Historical ComparisonAbout HGLB Highland Global Allocation Fund
Highland Global Allocation Fund is a diversified, closed-end management investment company. The investment objective of the Fund is to seek long-term growth of capital and future income. The Fund seeks to achieve its investment objectives by investing in a portfolio of U.S. and foreign equity, debt, and money market securities. It may also invest in senior loans to domestic or foreign corporations, partnerships, and other entities that operate in a variety of industries and geographic regions.
About RGC Regencell Bioscience Holdings Limited
Regencell Bioscience Holdings Ltd is a bioscience company focusing on the research, development, and commercialization of TCM for the treatment of neurocognitive disorders and degenerations, specifically ADHD and ASD, and infectious diseases affecting people's immune systems.